Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

29.86 +1.97 (+7.06%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 Next >

PROCEPT BioRobotics (PRCT) Earnings Transcript ↗

August 06, 2025

Via The Motley Fool

Topics World Trade

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗

August 06, 2025

PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces...

Via Chartmill

Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

How Is The Market Feeling About PROCEPT BioRobotics? ↗

January 24, 2025

Via Benzinga

Spruce Point Sees Trouble Ahead For Procept BioRobotics ↗

January 16, 2025

Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.

Via Benzinga

5 Analysts Assess PROCEPT BioRobotics: What You Need To Know ↗

December 02, 2024

Via Benzinga

Looking Into PROCEPT BioRobotics's Recent Short Interest ↗

November 14, 2024

Via Benzinga

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics ↗

November 14, 2024

Via Benzinga

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

2 Robotics Stocks Riding the Sensor and Medical Boom ↗

October 29, 2025

The robotics infrastructure layer is delivering explosive returns.

Via The Motley Fool

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗

October 24, 2025

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?

Via The Motley Fool

Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗

October 15, 2025

Via Benzinga

Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗

September 02, 2025

Via Benzinga

Procept (PRCT) Q2 Revenue Jumps 48% ↗

August 06, 2025

Via The Motley Fool

Topics Artificial Intelligence

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Where PROCEPT BioRobotics Stands With Analysts ↗

April 25, 2025

Via Benzinga

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

4 Analysts Assess PROCEPT BioRobotics: What You Need To Know ↗

February 26, 2025

Via Benzinga

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 02, 2024

Via Benzinga

Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? ↗

November 03, 2024

Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).

Via Benzinga

Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens ↗

October 28, 2024

Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.

Via Investor's Business Daily

PROCEPT BioRobotics's Earnings Outlook ↗

October 25, 2024

Via Benzinga

What Analysts Are Saying About PROCEPT BioRobotics Stock ↗

October 08, 2024

Via Benzinga

Navigating 6 Analyst Ratings For PROCEPT BioRobotics ↗

September 16, 2024

Via Benzinga

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential ↗

October 28, 2024

PROCEPT BioRobotics stock gains as Q3 earnings beat estimates with revenue up 66% YoY, driven by strong system sales and consumable revenue growth.

Via Benzinga

Topics Earnings

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

October 28, 2024

Via Benzinga

Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise ↗

October 28, 2024

The company sells systems that perform aquablation to treat enlarged prostates.

Via Investor's Business Daily

Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good' ↗

September 04, 2024

Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions